Australia's groundbreaking initiative, the Australian DNA Bridge Study (BRIDGE), is set to revolutionize genetic health research by addressing a critical gap in the field. This ambitious project aims to unlock valuable health insights for populations with mixed European and Asian ancestry, a demographic that has been largely overlooked in global genetic studies.
The study, led by Professor Loic Yengo from the University of Queensland's Institute of Molecular Bioscience, highlights a stark reality in genetics research. Over 90% of global genetic health studies have focused on people of European descent, despite these individuals comprising less than 20% of the world's population. This imbalance has significant implications, as it means that genetic health risk data, which could be life-saving, is not accessible to those of non-European descent or mixed ancestry.
Professor Yengo emphasizes the importance of this study, stating, 'We want to translate findings to as many populations and ancestries as possible.' By focusing on individuals with mixed European and Asian ancestry, the study aims to bridge the gap between European and Asian genetic research, offering a more comprehensive understanding of genetic health risks.
The first phase of the study will involve participants with one parent of Asian descent and another of European heritage. These participants will be asked to complete a questionnaire and provide a saliva sample. This approach is significant because it is the first study of its kind to target participants with multiple genetic ancestries, and it addresses the challenge of analyzing the genomes of individuals from mixed ancestry populations.
Professor Yengo explains, 'We have now built enough scientific knowledge to reliably analyze the genomes of individuals from mixed ancestry populations, which are a growing demographic globally.' The study's ability to measure genetic expression on both the European and Asian sides will provide valuable insights into genetic differences, free from the influence of environmental factors such as diet, exercise, and socio-economic status.
The broader implications of this study are profound. By identifying health risks early, the research team hopes to offer interventions earlier in people's lives, potentially preventing serious diseases. Dr. Yengo emphasizes the study's contribution to a longer-term goal of health prevention, which could have a significant impact on public health.
The research team aims to recruit 1000 participants for the first phase of the study, which will focus on European and Asian mixed ancestry. The second phase will explore another ancestry mix, further expanding the study's reach and impact. This ambitious project is funded by the Snow Medical Research Foundation through Professor Yengo's Snow Fellowship, an 8-year $8 million initiative supporting groundbreaking research.
In conclusion, the Australian DNA Bridge Study is a pioneering effort to address a critical gap in genetic health research. By focusing on mixed ancestry populations, the study has the potential to unlock valuable health insights, improve early disease detection, and contribute to a more equitable approach to global health.
